HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Possible regulation of soluble ICAM-1 levels by interleukin-1 in a sub-set of breast cysts.

Abstract
There are 2 main groups of breast cysts characterized by their intracystic sodium-to-potassium ratios. Women who have intracystic Na/K < 3 may have a higher risk of developing breast cancer than those who have intracystic Na/K > 3. The cell adhesion molecule, ICAM-I, has been shown to be inducible by interleukin-I (IL-I). Furthermore, ICAM-I may be involved in the progression of metastasis in certain malignancies. The aim of this study was to measure intracystic soluble ICAM-I (sICAM-I) and IL-I alpha/beta levels and to assess the relationships between these substances. Wide-ranging concentrations of sICAM-I, IL-I alpha and IL-I beta were found in breast-cyst fluid. The high-electrolyte-ratio group had intracystic levels of sICAM-I and IL-I beta which were significantly higher than those of the low-electrolyte-ratio group. No significant difference was found between IL-I alpha concentrations in the 2 groups of breast cysts. Strong positive correlations were found between sICAM-I and IL-I alpha, sICAM-I and IL-I beta, and IL-I alpha and IL-I beta. The significance of the higher concentrations of sICAM-I in the high-electrolyte-ratio group remains to be determined, but the results of this study suggest that sICAM-I levels in the high-electrolyte-ratio group may be regulated in part by IL-I alpha and IL-I beta.
AuthorsL C Lai, S Kadory, C Cornell, T W Lennard
JournalInternational journal of cancer (Int J Cancer) Vol. 55 Issue 4 Pg. 586-9 (Oct 21 1993) ISSN: 0020-7136 [Print] United States
PMID8406986 (Publication Type: Journal Article)
Chemical References
  • Cell Adhesion Molecules
  • Interleukin-1
  • Sodium
  • Potassium
Topics
  • Cell Adhesion Molecules (metabolism)
  • Female
  • Fibrocystic Breast Disease (metabolism)
  • Humans
  • Interleukin-1 (metabolism)
  • Potassium (metabolism)
  • Risk
  • Sodium (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: